GoodRx Holdings
GDRX
170 hedge funds and large institutions have $633M invested in GoodRx Holdings in 2024 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 48 closing their positions.
253% more call options, than puts
Call options by funds: $4.22M | Put options by funds: $1.2M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
31% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 35
10% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 48
1% more funds holding
Funds holding: 169 → 170 (+1)
6.73% less ownership
Funds ownership: 153.99% → 147.26% (-6.7%)
40% less capital inflows, than outflows
Capital inflows: $71.8M | Capital outflows: $119M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
+$6.93M |
| 2 |
Lakewood Capital Management
New York
|
+$6.41M |
| 3 |
Rubric Capital Management (New York)
New York
|
+$6.18M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.51M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$26.5M |
| 2 |
Silvercrest Asset Management
New York
|
-$16.7M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$12.4M |
| 4 |
Millennium Management
New York
|
-$11.7M |
| 5 |
Woodline Partners
San Francisco,
California
|
-$7.29M |
GDRX Hedge Fund Activity: Q4 2024 in Review
170 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2024, worth a combined $633M — down 36% from $988M a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new GDRX positions and 48 closed out — a net gain of 5 holders — while 46 added to existing stakes and 35 trimmed.
The largest buyer was ClearBridge Investments, opening a new position worth an estimated $6.93M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $26.5M sold.
- 170 institutional investors held GoodRx Holdings (GDRX) as of Q4 2024, up from 169 in Q3 2024.
- Funds reported $633M of GoodRx Holdings stock for Q4 2024, down 36% quarter-over-quarter.
- 53 funds opened new GoodRx Holdings positions in Q4 2024 and 48 closed out, a net change of +5 holders.
- The largest GoodRx Holdings buyer in Q4 2024 was ClearBridge Investments, an estimated $6.93M added.
- The largest GoodRx Holdings seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $26.5M sold.
Based on aggregated 13F filings for Q4 2024.